Protagonist Therapeutics, Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 20.06M30.93M0.23M28.63M27.36M26.58M60.00M434.43M
Gross Profit 20.06M30.93M0.23M28.63M27.36M26.58M60.00M434.43M
Operating items
Research & Development 25.70M46.18M59.50M65.00M74.51M126.01M126.22M120.16M138.13M
Selling, General & Administrative 6.96M11.78M13.70M15.75M18.64M27.20M31.74M33.49M43.46M
Operating Expenses 32.67M57.96M73.19M80.75M93.14M153.20M157.95M153.65M181.59M
Operating Income -32.67M-37.90M-42.27M-80.52M-64.52M-125.84M-131.37M-93.65M252.84M
EBIT -32.67M-37.90M-42.27M-80.52M-64.52M-125.84M-131.37M-93.65M252.84M
Non-operating items
Interest & Investment Income 0.24M0.95M2.57M2.81M0.90M0.44M4.06M14.90M26.32M
Other Non Operating Income -0.03M-0.01M-0.02M-0.00M-0.58M-0.15M-0.08M-0.20M0.25M
Non Operating Income -0.03M-0.01M-0.02M-0.00M-0.05M-0.15M-0.08M-0.20M0.25M
Net income details
EBT -37.18M-36.96M-39.72M-77.88M-71.07M-125.80M-127.39M-78.95M279.41M
Tax Provisions -0.80M-0.70M1.30M4.22M
Profit After Tax -37.18M-36.96M-38.92M-77.19M-66.15M-125.55M-127.39M-78.95M275.19M
Income from Continuing Operations -37.18M-36.96M-38.92M-77.18M-72.38M-125.80M-127.39M-78.95M275.19M
Consolidated Net Income -37.18M-36.96M-38.92M-77.18M-72.38M-125.80M-127.39M-78.95M275.19M
Income towards Parent Company -37.18M-36.96M-38.92M-77.18M-72.38M-125.80M-127.39M-78.95M275.19M
Net Income towards Common Stockholders -37.18M-36.96M-38.92M-77.18M-72.38M-125.80M-127.39M-78.95M275.19M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 16.71M20.48M24.19M27.21M38.26M47.73M49.20M57.68M59.60M
Shares Outstanding (Diluted Average) 46.32M56.76M65.08M
EBITDA -32.67M-37.90M-42.27M-80.52M-64.52M-125.84M-131.37M-93.65M252.84M
Tax Rate 2.01%0.90%1.51%